<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 17:18:07 BST</pubDate>


	<title>CiteULike: jyuh London</title>
	<description>CiteULike: jyuh London</description>


	<link>http://www.citeulike.org/user/jyuh/author/London</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/2796228"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/jyuh/article/2796228">
    <title>Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications</title>
    <link>http://www.citeulike.org/user/jyuh/article/2796228</link>
    <description>&lt;i&gt;Proceedings of the National Academy of Sciences, Vol. 105, No. 19. (13 May 2008), pp. 6998-7003.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Significant morbidity and mortality among patients with diabetes mellitus result largely from a greatly increased incidence of microvascular complications. Proliferative diabetic retinopathy (PDR) and end stage renal disease (ESRD) are two of the most common and severe microvascular complications of diabetes. A high concordance exists in the development of PDR and ESRD in diabetic patients, as well as strong familial aggregation of these complications, suggesting a common underlying genetic mechanism. However, the precise gene(s) and genetic variant(s) involved remain largely unknown. Erythropoietin (EPO) is a potent angiogenic factor observed in the diabetic human and mouse eye. By a combination of case-control association and functional studies, we demonstrate that the T allele of SNP rs1617640 in the promoter of the EPO gene is significantly associated with PDR and ESRD in three European-American cohorts [Utah: P = 1.91 x 10-3; Genetics of Kidneys in Diabetes (GoKinD) Study: P = 2.66 x 10-8; and Boston: P = 2.1 x 10-2]. The EPO concentration in human vitreous body was 7.5-fold higher in normal subjects with the TT risk genotype than in those with the GG genotype. Computational analysis suggests that the risk allele (T) of rs1617640 creates a matrix match with the EVI1/MEL1 or AP1 binding site, accounting for an observed 25-fold enhancement of luciferase reporter expression as compared with the G allele. These results suggest that rs1617640 in the EPO promoter is significantly associated with PDR and ESRD. This study identifies a disease risk-associated gene and potential pathway mediating severe diabetic microvascular complications. 10.1073/pnas.0800454105</description>
    <dc:title>Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications</dc:title>

    <dc:creator>Zongzhong Tong</dc:creator>
    <dc:creator>Zhenglin Yang</dc:creator>
    <dc:creator>Shrena Patel</dc:creator>
    <dc:creator>Haoyu Chen</dc:creator>
    <dc:creator>Daniel Gibbs</dc:creator>
    <dc:creator>Xian Yang</dc:creator>
    <dc:creator>Vincent Hau</dc:creator>
    <dc:creator>Yuuki Kaminoh</dc:creator>
    <dc:creator>Jennifer Harmon</dc:creator>
    <dc:creator>Erik Pearson</dc:creator>
    <dc:creator>Jeanette Buehler</dc:creator>
    <dc:creator>Yuhong Chen</dc:creator>
    <dc:creator>Baifeng Yu</dc:creator>
    <dc:creator>Nicholas Tinkham</dc:creator>
    <dc:creator>Norman Zabriskie</dc:creator>
    <dc:creator>Jiexi Zeng</dc:creator>
    <dc:creator>Ling Luo</dc:creator>
    <dc:creator>Jennifer Sun</dc:creator>
    <dc:creator>Manvi Prakash</dc:creator>
    <dc:creator>Rola Hamam</dc:creator>
    <dc:creator>Stephen Tonna</dc:creator>
    <dc:creator>Ryan Constantine</dc:creator>
    <dc:creator>Cecinio Ronquillo</dc:creator>
    <dc:creator>Srinivas Sadda</dc:creator>
    <dc:creator>Robert Avery</dc:creator>
    <dc:creator>John Brand</dc:creator>
    <dc:creator>Nyall London</dc:creator>
    <dc:creator>Alfred Anduze</dc:creator>
    <dc:creator>George King</dc:creator>
    <dc:creator>Paul Bernstein</dc:creator>
    <dc:creator>Scott Watkins</dc:creator>
    <dc:creator>Genetics</dc:creator>
    <dc:creator>Lynn Jorde</dc:creator>
    <dc:creator>Dean Li</dc:creator>
    <dc:creator>Lloyd Aiello</dc:creator>
    <dc:creator>Martin Pollak</dc:creator>
    <dc:creator>Kang Zhang</dc:creator>
    <dc:identifier>doi:10.1073/pnas.0800454105</dc:identifier>
    <dc:source>Proceedings of the National Academy of Sciences, Vol. 105, No. 19. (13 May 2008), pp. 6998-7003.</dc:source>
    <dc:date>2008-05-13T23:41:12-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>Proceedings of the National Academy of Sciences</prism:publicationName>
    <prism:volume>105</prism:volume>
    <prism:number>19</prism:number>
    <prism:startingPage>6998</prism:startingPage>
    <prism:endingPage>7003</prism:endingPage>
    <prism:category>dn</prism:category>
    <prism:category>epo</prism:category>
    <prism:category>snp</prism:category>
</item>



</rdf:RDF>

